Index | NOA group (n = 16) | Control group (n = 16) | P-value |
---|---|---|---|
Age (years) | 27.25 ± 3.61 | 29.50 ± 5.03 | 0.233 |
FSH (IU/L) | 21.30 ± 6.86* | 5.13 ± 2.94 | 0.000 |
LH (IU/L) | 10.44 ± 4.34* | 4.64 ± 1.92 | 0.000 |
T (ng/ml) | 3.27 ± 2.39 | 4.60 ± 2.12 | 0.053 |
PRL (ng/ml) | 12.65 ± 4.82 | 9.91 ± 4.26 | 0.254 |
E2 (pg/ml) | 20.59 ± 13.68 | 26.55 ± 9.10 | 0.143 |
P (ng/ml) | 0.50 ± 0.27 | 3.11 ± 9.31 | 0.877 |
Left testis volume (ml) | 7.44 ± 1.93* | 13.44 ± 3.85 | 0.000 |
Right testis volume (ml) | 8.00 ± 2.66* | 13.44 ± 3.85 | 0.000 |
Number of patients with abnormal secondary sexual characteristics no./total no. (%) | 0/16 (0) | 0/16 (0) | 1.000 |
Number of patients with varicocele no./total no. (%) | 0/16 (0) | 0/16 (0) | 1.000 |
Number of patients with genital abnormalities no./total no. (%) | 0/16 (0) | 0/16 (0) | 1.000 |
Number of patients with abnormal karyotype no./total no. (%) | 0/16 (0) | 0/16 (0) | 1.000 |
Number of patients with Y chromosome microdeletions no./total no. (%) | 0/16 (0) | 0/16 (0) | 1.000 |